0001209191-18-031233.txt : 20180517 0001209191-18-031233.hdr.sgml : 20180517 20180517201742 ACCESSION NUMBER: 0001209191-18-031233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180515 FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIDDER KENNETH J CENTRAL INDEX KEY: 0001065168 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 18844795 MAIL ADDRESS: STREET 1: 10070 BARNES CANYON ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-15 0 0000353569 QUIDEL CORP /DE/ QDEL 0001065168 WIDDER KENNETH J 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2018-05-16 4 M 0 2016 0.00 A 7595 D Common Stock 2018-05-17 4 M 0 510 0.00 A 8105 D Common Stock 2018-05-17 4 M 0 2550 0.00 A 10655 D Restricted Stock Units (Converted) 2018-05-15 4 A 0 791 0.00 A Common Stock 791 791 D Restricted Stock Units (Premium) 2018-05-15 4 A 0 237 0.00 A Common Stock 237 237 D Restricted Stock Units (Equity Grant) 2018-05-15 4 A 0 1661 0.00 A Common Stock 1661 1661 D Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Each restricted stock unit represents the right to receive one share of Quidel Corporation common Stock. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. The restricted stock units vest on the date of grant, May 15, 2018. The restricted stock units vest on May 15, 2019. Robert J. Bujarski, attorney-in-fact for Kenneth J. Widder 2018-05-17